Bridging Kidney Organoid Innovation and Regenerative Medicine: Current Advances and Future Directions

Abstract

Chronic kidney disease (CKD) has emerged as a critical public health challenge worldwide, and organ donor shortages underscore the urgent need for alternative therapeutic strategies. Advances in stem cell technologies have enabled the generation of kidney organoids, providing innovative platforms to model renal development, investigate disease mechanisms, support drug discovery, and explore applications in regenerative medicine. Yet, limitations such as immature tissue architecture, insufficient vascularisation, and unaddressed safety concerns still hinder their translation into regenerative medicine. In this review, we summarise the fundamentals of kidney development, current differentiation approaches, and the signalling and epigenetic mechanisms underlying organoid lineage specification. We further highlight the roles of bioengineering innovations and single-cell transcriptomics in establishing evaluation frameworks and enhancing structural complexity. We finally emphasise that existing optimisation frameworks, primarily focused on improving differentiation efficiency and enforcing relatively restricted lineage specification, may prove inadequate for bridging the gap to clinical translation. Instead, the most promising paradigm shift involves the convergence of bioengineering modulation and high-resolution functional assessment to facilitate the synchronised advancement of organoid complexity and physiological utility.

Keywords

bioengineering / epigenetic regulation / kidney organoids / regenerative medicine / signalling pathways / single-cell transcriptomics

References

[1] KDIGO, “Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease,” Kidney International 105, no. 4s (2024): S117–S314, https://doi.org/10.1016/j.kint.2023.10.018.

[2] K. L. Lentine, J. M. Smith, G. R. Lyden, et al., “OPTN/SRTR 2023 Annual Data Report: Kidney,” American Journal of Transplantation 25, no. 2s1 (2025): S22–S137, https://doi.org/10.1016/j.ajt.2025.01.020.

[3] K. Takahashi, K. Tanabe, M. Ohnuki, et al., “Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors,” Cell 131, no. 5 (2007): 861–872, https://doi.org/10.1016/j.cell.2007.11.019.

[4] Y. Xia, I. Sancho-Martinez, E. Nivet, C. Rodriguez Esteban, J. M. Campistol, and J. C. Izpisua Belmonte, “The Generation of Kidney Organoids by Differentiation of Human Pluripotent Cells to Ureteric Bud Progenitor-Like Cells,” Nature Protocols 9, no. 11 (2014): 2693–2704, https://doi.org/10.1038/nprot.2014.182.

[5] A. Taguchi, Y. Kaku, T. Ohmori, et al., “Redefining the In Vivo Origin of Metanephric Nephron Progenitors Enables Generation of Complex Kidney Structures From Pluripotent Stem Cells,” Cell Stem Cell 14, no. 1 (2014): 53–67, https://doi.org/10.1016/j.stem.2013.11.010.

[6] M. Takasato, P. X. Er, H. S. Chiu, et al., “Kidney Organoids From Human iPS Cells Contain Multiple Lineages and Model Human Nephrogenesis,” Nature 526, no. 7574 (2015): 564–568, https://doi.org/10.1038/nature15695.

[7] R. Morizane, A. Q. Lam, B. S. Freedman, S. Kishi, M. T. Valerius, and J. V. Bonventre, “Nephron Organoids Derived From Human Pluripotent Stem Cells Model Kidney Development and Injury,” Nature Biotechnology 33, no. 11 (2015): 1193–1200, https://doi.org/10.1038/nbt.3392.

[8] B. S. Freedman, C. R. Brooks, A. Q. Lam, et al., “Modelling Kidney Disease With CRISPR-Mutant Kidney Organoids Derived From Human Pluripotent Epiblast Spheroids,” Nature Communications 6 (2015): 8715, https://doi.org/10.1038/ncomms9715.

[9] A. Taguchi and R. Nishinakamura, “Higher-Order Kidney Organogenesis From Pluripotent Stem Cells,” Cell Stem Cell 21, no. 6 (2017): 730–746, https://doi.org/10.1016/j.stem.2017.10.011.

[10] M. Shi, K. W. McCracken, A. B. Patel, et al., “Human Ureteric Bud Organoids Recapitulate Branching Morphogenesis and Differentiate Into Functional Collecting Duct Cell Types,” Nature Biotechnology 41, no. 2 (2023): 252–261, https://doi.org/10.1038/s41587-022-01429-5.

[11] C. E. Vishy, C. Thomas, T. Vincent, D. K. Crawford, M. M. Goddeeris, and B. S. Freedman, “Genetics of Cystogenesis in Base-Edited Human Organoids Reveal Therapeutic Strategies for Polycystic Kidney Disease,” Cell Stem Cell 31, no. 4 (2024): 537–553, https://doi.org/10.1016/j.stem.2024.03.005.

[12] H. Wu, Y. Ning, Z. Sun, et al., “Both Carvedilol and Cimetidine Alleviate Cisplatin-Induced Nephrotoxicity via Downregulating OCT2,” Biochimica et Biophysica Acta - Molecular Basis of Disease 1871, no. 5 (2025): 167754, https://doi.org/10.1016/j.bbadis.2025.167754.

[13] C. Formica, G. Addario, S. Fagiolino, L. Moroni, and C. Mota, “Microfluidic Bioprinting as a Tool to Produce hiPSCs-Derived Renal Organoids,” Biofabrication 17, no. 3 (2025): 35016, https://doi.org/10.1088/1758-5090/addb7e.

[14] D. Kim, H. Lim, J. Youn, T. E. Park, and D. S. Kim, “Scalable Production of Uniform and Mature Organoids in a 3D Geometrically-Engineered Permeable Membrane,” Nature Communications 15, no. 1 (2024): 9420, https://doi.org/10.1038/s41467-024-53073-z.

[15] H. Wu, K. Uchimura, E. L. Donnelly, Y. Kirita, S. A. Morris, and B. D. Humphreys, “Comparative Analysis and Refinement of Human PSC-Derived Kidney Organoid Differentiation With Single-Cell Transcriptomics,” Cell Stem Cell 23, no. 6 (2018): 869–881, https://doi.org/10.1016/j.stem.2018.10.010.

[16] S. B. Wilson, S. E. Howden, J. M. Vanslambrouck, et al., “DevKidCC Allows for Robust Classification and Direct Comparisons of Kidney Organoid Datasets,” Genome Medicine 14, no. 1 (2022): 19, https://doi.org/10.1186/s13073-022-01023-z.

[17] B. Huang, Z. Zeng, S. Kim, et al., “Long-Term Expandable Mouse and Human-Induced Nephron Progenitor Cells Enable Kidney Organoid Maturation and Modeling of Plasticity and Disease,” Cell Stem Cell 31, no. 6 (2024): 921–939, https://doi.org/10.1016/j.stem.2024.04.002.

[18] S. I. Mae, F. Hattanda, H. Morita, et al., “Human iPSC-Derived Renal Collecting Duct Organoid Model Cystogenesis in ADPKD,” Cell Reports 42, no. 12 (2023): 113431, https://doi.org/10.1016/j.celrep.2023.113431.

[19] J. M. Vanslambrouck, S. B. Wilson, K. S. Tan, et al., “Enhanced Metanephric Specification to Functional Proximal Tubule Enables Toxicity Screening and Infectious Disease Modelling in Kidney Organoids,” Nature Communications 13, no. 1 (2022): 5943, https://doi.org/10.1038/s41467-022-33623-z.

[20] E. Garreta, D. Moya-Rull, A. Centeno, et al., “Systematic Production of Human Kidney Organoids for Transplantation in Porcine Kidneys During Ex Vivo Machine Perfusion,” Nature Biomedical Engineering (2025): 1–18, https://doi.org/10.1038/s41551-025-01542-1.

[21] H. Levassort and M. Essig, “The Kidney, Its Anatomy and Main Functions,” Soins Gerontol 29, no. 165 (2024): 10–20, https://doi.org/10.1016/j.sger.2023.12.003.

[22] “Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017,” Lancet 395, no. 10225 (2020): 709–733, https://doi.org/10.1016/s0140-6736(20)30045-3.

[23] “Global, Regional, and National Prevalence of Kidney Failure With Replacement Therapy and Associated Aetiologies, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023,” Lancet Global Health 13, no. 8 (2025): e1378–e1395, https://doi.org/10.1016/s2214-109x(25)00198-6.

[24] R. Vanholder, L. Annemans, A. K. Bello, et al., “Fighting the Unbearable Lightness of Neglecting Kidney Health: The Decade of the Kidney,” Clinical Kidney Journal 14, no. 7 (2021): 1719–1730, https://doi.org/10.1093/ckj/sfab070.

[25] J. Wang, W. Xie, N. Li, et al., “Generation of a Humanized Mesonephros in Pigs From Induced Pluripotent Stem Cells via Embryo Complementation,” Cell Stem Cell 30, no. 9 (2023): 1235–1245, https://doi.org/10.1016/j.stem.2023.08.003.

[26] Y. Wang, G. Chen, D. Pan, et al., “Pig-to-Human Kidney Xenotransplants Using Genetically Modified Minipigs,” Cell Reports Medicine 5, no. 10 (2024): 101744, https://doi.org/10.1016/j.xcrm.2024.101744.

[27] K. Fujimori, S. Yamanaka, K. Shimada, et al., “Generation of Human-Pig Chimeric Renal Organoids Using iPSC Technology,” Communications Biology 7, no. 1 (2024): 1278, https://doi.org/10.1038/s42003-024-06986-w.

[28] S. Li, Q. Nlandu, T. P. P. van den Bosch, C. C. Baan, R. Kramann, and M. J. Hoogduijn, “Modeling Kidney Fibrosis and Tubular Regeneration in iPSC-Derived Kidney Organoids,” Stem Cell Research & Therapy 17, no. 1 (2025): 40, https://doi.org/10.1186/s13287-025-04866-6.

[29] K. Park, W. W. Gao, J. Zheng, K. T. Oh, I. Y. Kim, and S. You, “Hydrogel-Mediated Local Delivery of Induced Nephron Progenitor Cell-Sourced Molecules as a Cell-Free Approach for Acute Kidney Injury,” International Journal of Molecular Sciences 25, no. 19 (2024): 10615, https://doi.org/10.3390/ijms251910615.

[30] T. Araoka, K. Toyohara, M. Ryosaka, et al., “Human iPSC-Derived Nephron Progenitor Cells Treat Acute Kidney Injury and Chronic Kidney Disease in Mouse Models,” Science Translational Medicine 17, no. 792 (2025): eadt5553, https://doi.org/10.1126/scitranslmed.adt5553.

[31] M. H. Little and A. P. McMahon, “Mammalian Kidney Development: Principles, Progress, and Projections,” Cold Spring Harbor Perspectives in Biology 4, no. 5 (2012): a008300, https://doi.org/10.1101/cshperspect.a008300.

[32] A. P. McMahon, “Chapter Three—Development of the Mammalian Kidney,” in Current Topics in Developmental Biology, ed. P. M. Wassarman (Academic Press, 2016), 31–64.

[33] H. A. Hartman, H. L. Lai, and L. T. Patterson, “Cessation of Renal Morphogenesis in Mice,” Developmental Biology 310, no. 2 (2007): 379–387, https://doi.org/10.1016/j.ydbio.2007.08.021.

[34] K. M. Schmidt-Ott, J. Yang, X. Chen, et al., “Novel Regulators of Kidney Development From the Tips of the Ureteric Bud,” American Society of Nephrology 16, no. 7 (2005): 1993–2002, https://doi.org/10.1681/asn.2004121127.

[35] R. Kopan, S. Chen, and M. Little, “Nephron Progenitor Cells: Shifting the Balance of Self-Renewal and Differentiation,” Current Topics in Developmental Biology 107 (2014): 293–331, https://doi.org/10.1016/b978-0-12-416,022-4.00011-1.

[36] S. Tanigawa, E. Tanaka, K. Miike, et al., “Generation of the Organotypic Kidney Structure by Integrating Pluripotent Stem Cell-Derived Renal Stroma,” Nature Communications 13, no. 1 (2022): 611, https://doi.org/10.1038/s41467-022-28226-7.

[37] R. Nishinakamura, “Advances and Challenges Toward Developing Kidney Organoids for Clinical Applications,” Cell Stem Cell 30, no. 8 (2023): 1017–1027, https://doi.org/10.1016/j.stem.2023.07.011.

[38] B. Song, A. M. Smink, C. V. Jones, et al., “The Directed Differentiation of Human iPS Cells Into Kidney Podocytes,” PLoS One 7, no. 9 (2012): e46453, https://doi.org/10.1371/journal.pone.0046453.

[39] S. I. Mae, A. Shono, F. Shiota, et al., “Monitoring and Robust Induction of Nephrogenic Intermediate Mesoderm From Human Pluripotent Stem Cells,” Nature Communications 4 (2013): 1367, https://doi.org/10.1038/ncomms2378.

[40] H. Tsujimoto, T. Kasahara, S. I. Sueta, et al., “A Modular Differentiation System Maps Multiple Human Kidney Lineages From Pluripotent Stem Cells,” Cell Reports 31, no. 1 (2020): 107476, https://doi.org/10.1016/j.celrep.2020.03.040.

[41] K. Uchimura, H. Wu, Y. Yoshimura, and B. D. Humphreys, “Human Pluripotent Stem Cell-Derived Kidney Organoids With Improved Collecting Duct Maturation and Injury Modeling,” Cell Reports 33, no. 11 (2020): 108514, https://doi.org/10.1016/j.celrep.2020.108514.

[42] S. I. Mae, M. Ryosaka, S. Sakamoto, et al., “Expansion of Human iPSC-Derived Ureteric Bud Organoids With Repeated Branching Potential,” Cell Reports 32, no. 4 (2020): 107963, https://doi.org/10.1016/j.celrep.2020.107963.

[43] M. Takasato, P. X. Er, H. S. Chiu, et al., “Kidney Organoids From Human iPS Cells Contain Multiple Lineages and Model Human Nephrogenesis,” Nature 536, no. 7615 (2016): 238, https://doi.org/10.1038/nature17982.

[44] R. Morizane and J. V. Bonventre, “Generation of Nephron Progenitor Cells and Kidney Organoids From Human Pluripotent Stem Cells,” Nature Protocols 12, no. 1 (2017): 195–207, https://doi.org/10.1038/nprot.2016.170.

[45] S. E. Howden, J. M. Vanslambrouck, S. B. Wilson, K. S. Tan, and M. H. Little, “Reporter-Based Fate Mapping in Human Kidney Organoids Confirms Nephron Lineage Relationships and Reveals Synchronous Nephron Formation,” EMBO Reports 20, no. 4 (2019): e47483, https://doi.org/10.15252/embr.201847483.

[46] J. H. Low, P. Li, E. G. Y. Chew, et al., “Generation of Human PSC-Derived Kidney Organoids With Patterned Nephron Segments and a De Novo Vascular Network,” Cell Stem Cell 25, no. 3 (2019): 373–387, https://doi.org/10.1016/j.stem.2019.06.009.

[47] Z. Zeng, B. Huang, R. K. Parvez, et al., “Generation of Patterned Kidney Organoids That Recapitulate the Adult Kidney Collecting Duct System From Expandable Ureteric Bud Progenitors,” Nature Communications 12, no. 1 (2021): 3641, https://doi.org/10.1038/s41467-021-23911-5.

[48] E. Tzouanacou, A. Wegener, F. J. Wymeersch, V. Wilson, and J. F. Nicolas, “Redefining the Progression of Lineage Segregations During Mammalian Embryogenesis by Clonal Analysis,” Developmental Cell 17, no. 3 (2009): 365–376, https://doi.org/10.1016/j.devcel.2009.08.002.

[49] M. Takasato, P. X. Er, M. Becroft, et al., “Directing Human Embryonic Stem Cell Differentiation Towards a Renal Lineage Generates a Self-Organizing Kidney,” Nature Cell Biology 16, no. 1 (2014): 118–126, https://doi.org/10.1038/ncb2894.

[50] D. Sweetman, L. Wagstaff, O. Cooper, C. Weijer, and A. Münsterberg, “The Migration of Paraxial and Lateral Plate Mesoderm Cells Emerging From the Late Primitive Streak Is Controlled by Different Wnt Signals,” BMC Developmental Biology 8 (2008): 63, https://doi.org/10.1186/1471-213x-8-63.

[51] M. Takasato and M. H. Little, “The Origin of the Mammalian Kidney: Implications for Recreating the Kidney In Vitro,” Development 142, no. 11 (2015): 1937–1947, https://doi.org/10.1242/dev.104802.

[52] C. Lengerke, S. Schmitt, T. V. Bowman, et al., “BMP and Wnt Specify Hematopoietic Fate by Activation of the Cdx-Hox Pathway,” Cell Stem Cell 2, no. 1 (2008): 72–82, https://doi.org/10.1016/j.stem.2007.10.022.

[53] T. Sumi, N. Tsuneyoshi, N. Nakatsuji, and H. Suemori, “Defining Early Lineage Specification of Human Embryonic Stem Cells by the Orchestrated Balance of Canonical Wnt/Beta-Catenin, Activin/Nodal and BMP Signaling,” Development 135, no. 17 (2008): 2969–2979, https://doi.org/10.1242/dev.021121.

[54] M. Kang and Y. M. Han, “Differentiation of Human Pluripotent Stem Cells Into Nephron Progenitor Cells in a Serum and Feeder Free System,” PLoS One 9, no. 4 (2014): e94888, https://doi.org/10.1371/journal.pone.0094888.

[55] M. A. Achieng, J. Schnell, C. C. Fausto, et al., “Axial Nephron Fate Switching Demonstrates a Plastic System Tunable on Demand,” Nature Communications 16, no. 1 (2025): 7912, https://doi.org/10.1038/s41467-025-63290-9.

[56] S. Yuri, M. Nishikawa, N. Yanagawa, O. D. Jo, and N. Yanagawa, “In Vitro Propagation and Branching Morphogenesis From Single Ureteric Bud Cells,” Stem Cell Reports 8, no. 2 (2017): 401–416, https://doi.org/10.1016/j.stemcr.2016.12.011.

[57] O. Michos, C. Cebrian, D. Hyink, et al., “Kidney Development in the Absence of Gdnf and Spry1 Requires Fgf10,” PLoS Genetics 6, no. 1 (2010): e1000809, https://doi.org/10.1371/journal.pgen.1000809.

[58] X. Chi, O. Michos, R. Shakya, et al., “Ret-Dependent Cell Rearrangements in the Wolffian Duct Epithelium Initiate Ureteric Bud Morphogenesis,” Developmental Cell 17, no. 2 (2009): 199–209, https://doi.org/10.1016/j.devcel.2009.07.013.

[59] A. Packard, W. H. Klein, and F. Costantini, “Ret Signaling in Ureteric Bud Epithelial Cells Controls Cell Movements, Cell Clustering and Bud Formation,” Development 148, no. 9 (2021): dev199386, https://doi.org/10.1242/dev.199386.

[60] G. R. Dressler, “Epigenetics, Development, and the Kidney,” Journal of the American Society of Nephrology 19, no. 11 (2008): 2060–2067, https://doi.org/10.1681/asn.2008010119.

[61] B. Huang, Z. Liu, A. Vonk, Z. Zeng, and Z. Li, “Epigenetic Regulation of Kidney Progenitor Cells,” Stem Cells Translational Medicine 9, no. 6 (2020): 655–660, https://doi.org/10.1002/sctm.19-0289.

[62] H. Liu, N. Y. N. Ngo, K. F. Herzberger, M. Gummaraju, S. Hilliard, and C. H. Chen, “Histone Deacetylases 1 and 2 Target Gene Regulatory Networks of Nephron Progenitors to Control Nephrogenesis,” Biochemical Pharmacology 206 (2022): 115341, https://doi.org/10.1016/j.bcp.2022.115341.

[63] N. Wanner, J. Vornweg, A. Combes, et al., “DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation,” Journal of the American Society of Nephrology 30, no. 1 (2019): 63–78, https://doi.org/10.1681/asn.2018070736.

[64] P. C. Wilson, N. Ledru, and B. D. Humphreys, “Epigenomics and the Kidney,” Current Opinion in Nephrology and Hypertension 29, no. 3 (2020): 280–285, https://doi.org/10.1097/mnh.0000000000000602.

[65] M. Adli, M. Parlak, Y. Li, and S. S. El-Dahr, “Epigenetic States of Nephron Progenitors and Epithelial Differentiation,” Journal of Cellular Biochemistry 116, no. 6 (2015): 893–902, https://doi.org/10.1002/jcb.25048.

[66] S. S. El-Dahr and Z. Saifudeen, “Epigenetic Regulation of Renal Development,” Seminars in Cell & Developmental Biology 91 (2019): 111–118, https://doi.org/10.1016/j.semcdb.2018.08.014.

[67] N. McLaughlin, F. Wang, Z. Saifudeen, and S. S. El-Dahr, “In Situ Histone Landscape of Nephrogenesis,” Epigenetics 9, no. 2 (2014): 222–235, https://doi.org/10.4161/epi.26793.

[68] S. Chen, X. Yao, Y. Li, Z. Saifudeen, D. Bachvarov, and S. S. El-Dahr, “Histone Deacetylase 1 and 2 Regulate Wnt and p53 Pathways in the Ureteric Bud Epithelium,” Development 142, no. 6 (2015): 1180–1192, https://doi.org/10.1242/dev.113506.

[69] V. K. Nagalakshmi, Q. Ren, M. M. Pugh, M. T. Valerius, A. P. McMahon, and J. Yu, “Dicer Regulates the Development of Nephrogenic and Ureteric Compartments in the Mammalian Kidney,” Kidney International 79, no. 3 (2011): 317–330, https://doi.org/10.1038/ki.2010.385.

[70] M. P. Bartram, M. Höhne, C. Dafinger, et al., “Conditional Loss of Kidney microRNAs Results in Congenital Anomalies of the Kidney and Urinary Tract (CAKUT),” Journal of Molecular Medicine (Berlin, Germany) 91, no. 6 (2013): 739–748, https://doi.org/10.1007/s00109-013-1000-x.

[71] R. Mao, J. Zhang, H. Qin, Y. Liu, Y. Xing, and W. Zeng, “Application Progress of Bio-Manufacturing Technology in Kidney Organoids,” Biofabrication 17, no. 2 (2025): 22007, https://doi.org/10.1088/1758-5090/adb4a1.

[72] A. Pahuja, I. Goux Corredera, D. Moya-Rull, E. Garreta, and N. Montserrat, “Engineering Physiological Environments to Advance Kidney Organoid Models From Human Pluripotent Stem Cells,” Current Opinion in Cell Biology 86 (2024): 102306, https://doi.org/10.1016/j.ceb.2023.102306.

[73] A. M. van Genderen, M. G. Valverde, P. E. Capendale, et al., “Co-Axial Printing of Convoluted Proximal Tubule for Kidney Disease Modeling,” Biofabrication 14, no. 4 (2022): 044102, https://doi.org/10.1088/1758-5090/ac7895.

[74] K. A. Homan, D. B. Kolesky, M. A. Skylar-Scott, et al., “Bioprinting of 3D Convoluted Renal Proximal Tubules on Perfusable Chips,” Scientific Reports 6 (2016): 34845, https://doi.org/10.1038/srep34845.

[75] M. Abdallah, S. Nagarajan, M. Martin, et al., “Enhancement of Podocyte Attachment on Polyacrylamide Hydrogels With Gelatin-Based Polymers,” ACS Applied Bio Materials 3, no. 11 (2020): 7531–7539, https://doi.org/10.1021/acsabm.0c00734.

[76] H. Choi, W. S. Choi, and J. O. Jeong, “A Review of Advanced Hydrogel Applications for Tissue Engineering and Drug Delivery Systems as Biomaterials,” Gels 10, no. 11 (2024): 693, https://doi.org/10.3390/gels10110693.

[77] H. Geckil, F. Xu, X. Zhang, S. Moon, and U. Demirci, “Engineering Hydrogels as Extracellular Matrix Mimics,” Nanomedicine (London, England) 5, no. 3 (2010): 469–484, https://doi.org/10.2217/nnm.10.12.

[78] S. Rashidi, G. Bagherpour, Z. Abbasi-Malati, et al., “Endothelial Progenitor Cells for Fabrication of Engineered Vascular Units and Angiogenesis Induction,” Cell Proliferation 57, no. 9 (2024): e13716, https://doi.org/10.1111/cpr.13716.

[79] N. J. Treacy, S. Clerkin, J. L. Davis, et al., “Growth and Differentiation of Human Induced Pluripotent Stem Cell (hiPSC)-Derived Kidney Organoids Using Fully Synthetic Peptide Hydrogels,” Bioactive Materials 21 (2023): 142–156, https://doi.org/10.1016/j.bioactmat.2022.08.003.

[80] B. A. Nerger, S. Sinha, N. N. Lee, et al., “3D Hydrogel Encapsulation Regulates Nephrogenesis in Kidney Organoids,” Advanced Materials 36, no. 14 (2024): e2308325, https://doi.org/10.1002/adma.202308325.

[81] E. Garreta, D. Moya-Rull, A. Marco, et al., “Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis,” Advanced Materials 36, no. 34 (2024): e2400306, https://doi.org/10.1002/adma.202400306.

[82] Y. Guan, S. Liu, Y. Liu, et al., “Porcine Kidneys as a Source of ECM Scaffold for Kidney Regeneration,” Materials Science & Engineering. C, Materials for Biological Applications 56 (2015): 451–456, https://doi.org/10.1016/j.msec.2015.07.007.

[83] K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, and G. Forgacs, “Tissue Engineering by Self-Assembly and Bio-Printing of Living Cells,” Biofabrication 2, no. 2 (2010): 22001, https://doi.org/10.1088/1758-5082/2/2/022001.

[84] J. Groll, T. Boland, T. Blunk, et al., “Biofabrication: Reappraising the Definition of an Evolving Field,” Biofabrication 8, no. 1 (2016): 13001, https://doi.org/10.1088/1758-5090/8/1/013001.

[85] X. Wang, X. Liu, W. Liu, et al., “3D Bioprinting Microgels to Construct Implantable Vascular Tissue,” Cell Proliferation 56, no. 5 (2023): e13456, https://doi.org/10.1111/cpr.13456.

[86] K. T. Lawlor, J. M. Vanslambrouck, J. W. Higgins, et al., “Cellular Extrusion Bioprinting Improves Kidney Organoid Reproducibility and Conformation,” Nature Materials 20, no. 2 (2021): 260–271, https://doi.org/10.1038/s41563-020-00853-9.

[87] Y. Ibi and R. Nishinakamura, “Generating Kidney Organoids Based on Developmental Nephrology,” European Journal of Cell Biology 103, no. 4 (2024): 151450, https://doi.org/10.1016/j.ejcb.2024.151450.

[88] N. Tabibzadeh and R. Morizane, “Advancements in Therapeutic Development: Kidney Organoids and Organs on a Chip,” Kidney International 105, no. 4 (2024): 702–708, https://doi.org/10.1016/j.kint.2023.11.035.

[89] G. Kiranmai, S. Chameettachal, Y. Sriya, et al., “Recent Trends in the Development Ofin Vitro3D Kidney Models,” Biofabrication 17, no. 2 (2025): 22010, https://doi.org/10.1088/1758-5090/adb999.

[90] S. Ghaffari, R. L. Leask, and E. A. Jones, “Flow Dynamics Control the Location of Sprouting and Direct Elongation During Developmental Angiogenesis,” Development 142, no. 23 (2015): 4151–4157, https://doi.org/10.1242/dev.128058.

[91] K. A. Homan, N. Gupta, K. T. Kroll, et al., “Flow-Enhanced Vascularization and Maturation of Kidney Organoids In Vitro,” Nature Methods 16, no. 3 (2019): 255–262, https://doi.org/10.1038/s41592-019-0325-y.

[92] R. Sobreiro-Almeida, M. E. Melica, L. Lasagni, P. Romagnani, and N. M. Neves, “Co-Cultures of Renal Progenitors and Endothelial Cells on Kidney Decellularized Matrices Replicate the Renal Tubular Environment In Vitro,” Acta Physiologica (Oxford, England) 230, no. 1 (2020): e13491, https://doi.org/10.1111/apha.13491.

[93] A. Bas-Cristóbal Menéndez, Z. Du, T. P. P. van den Bosch, et al., “Creating a Kidney Organoid-Vasculature Interaction Model Using a Novel Organ-On-Chip System,” Scientific Reports 12, no. 1 (2022): 20699, https://doi.org/10.1038/s41598-022-24945-5.

[94] T. Geuens, F. A. A. Ruiter, A. Schumacher, et al., “Thiol-Ene Cross-Linked Alginate Hydrogel Encapsulation Modulates the Extracellular Matrix of Kidney Organoids by Reducing Abnormal Type 1a1 Collagen Deposition,” Biomaterials 275 (2021): 120976, https://doi.org/10.1016/j.biomaterials.2021.120976.

[95] K. Hiratsuka, T. Miyoshi, K. T. Kroll, et al., “Organoid-on-a-Chip Model of Human ARPKD Reveals Mechanosensing Pathomechanisms for Drug Discovery,” Science Advances 8, no. 38 (2022): eabq0866, https://doi.org/10.1126/sciadv.abq0866.

[96] S. R. Li, R. E. Gulieva, L. Helms, et al., “Glucose Absorption Drives Cystogenesis in a Human Organoid-on-Chip Model of Polycystic Kidney Disease,” Nature Communications 13, no. 1 (2022): 7918, https://doi.org/10.1038/s41467-022-35537-2.

[97] S. Clerkin, K. Singh, J. L. Davis, et al., “Tuneable Gelatin Methacryloyl (GelMA) Hydrogels for the Directed Specification of Renal Cell Types for hiPSC-Derived Kidney Organoid Maturation,” Biomaterials 322 (2025): 123349, https://doi.org/10.1016/j.biomaterials.2025.123349.

[98] S. Mao, R. Xie, J. Shou, Y. Pang, and W. Sun, “Bioprinting of Patient-Derived Heterogeneous Renal Cell Carcinoma Organoids for Personalized Therapy,” Biofabrication 17, no. 4 (2025): 45008, https://doi.org/10.1088/1758-5090/adecc5.

[99] C. Ma, R. Banan Sadeghian, R. Negoro, et al., “Efficient Proximal Tubule-On-Chip Model From hiPSC-Derived Kidney Organoids for Functional Analysis of Renal Transporters,” iScience 27, no. 9 (2024): 110760, https://doi.org/10.1016/j.isci.2024.110760.

[100] P. C. Wilson and B. D. Humphreys, “Kidney and Organoid Single-Cell Transcriptomics: The End of the Beginning,” Pediatric Nephrology 35, no. 2 (2020): 191–197, https://doi.org/10.1007/s00467-018-4177-y.

[101] M. H. Little and A. N. Combes, “Kidney Organoids: Accurate Models or Fortunate Accidents,” Genes & Development 33, no. 19–20 (2019): 1319–1345, https://doi.org/10.1101/gad.329573.119.

[102] J. Hansen, R. Sealfon, R. Menon, et al., “A Reference Tissue Atlas for the Human Kidney,” Science Advances 8, no. 23 (2022): eabn4965, https://doi.org/10.1126/sciadv.abn4965.

[103] A. Schumacher, M. B. Rookmaaker, J. A. Joles, et al., “Defining the Variety of Cell Types in Developing and Adult Human Kidneys by Single-Cell RNA Sequencing,” npj Regenerative Medicine 6, no. 1 (2021): 45, https://doi.org/10.1038/s41536-021-00156-w.

[104] E. Bender, “How Organoids Are Advancing the Understanding of Chronic Kidney Disease,” Nature 615, no. 7951 (2023): S10–S11, https://doi.org/10.1038/d41586-023-00652-7.

[105] J. Park, C. L. Liu, J. Kim, and K. Susztak, “Understanding the Kidney One Cell at a Time,” Kidney International 96, no. 4 (2019): 862–870, https://doi.org/10.1016/j.kint.2019.03.035.

[106] D. Jovic, X. Liang, H. Zeng, L. Lin, F. Xu, and Y. Luo, “Single-Cell RNA Sequencing Technologies and Applications: A Brief Overview,” Clinical and Translational Medicine 12, no. 3 (2022): e694, https://doi.org/10.1002/ctm2.694.

[107] X. Wu, B. Yang, I. Udo-Inyang, et al., “Research Techniques Made Simple: Single-Cell RNA Sequencing and Its Applications in Dermatology,” Journal of Investigative Dermatology 138, no. 5 (2018): 1004–1009, https://doi.org/10.1016/j.jid.2018.01.026.

[108] X. Zhang, T. Li, F. Liu, et al., “Comparative Analysis of Droplet-Based Ultra-High-Throughput Single-Cell RNA-Seq Systems,” Molecular Cell 73, no. 1 (2019): 130–142, https://doi.org/10.1016/j.molcel.2018.10.020.

[109] A. Subramanian, E. H. Sidhom, M. Emani, et al., “Single Cell Census of Human Kidney Organoids Shows Reproducibility and Diminished Off-Target Cells After Transplantation,” Nature Communications 10, no. 1 (2019): 5462, https://doi.org/10.1038/s41467-019-13382-0.

[110] Y. Muto, P. C. Wilson, N. Ledru, et al., “Single Cell Transcriptional and Chromatin Accessibility Profiling Redefine Cellular Heterogeneity in the Adult Human Kidney,” Nature Communications 12, no. 1 (2021): 2190, https://doi.org/10.1038/s41467-021-22368-w.

[111] W. Safi, A. Marco, D. Moya, P. Prado, E. Garreta, and N. Montserrat, “Assessing Kidney Development and Disease Using Kidney Organoids and CRISPR Engineering,” Frontiers in Cell and Development Biology 10 (2022): 948395, https://doi.org/10.3389/fcell.2022.948395.

[112] A. N. Combes, L. Zappia, P. X. Er, A. Oshlack, and M. H. Little, “Single-Cell Analysis Reveals Congruence Between Kidney Organoids and Human Fetal Kidney,” Genome Medicine 11, no. 1 (2019): 3, https://doi.org/10.1186/s13073-019-0615-0.

[113] S. M. Czerniecki, N. M. Cruz, J. L. Harder, et al., “High-Throughput Screening Enhances Kidney Organoid Differentiation From Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping,” Cell Stem Cell 22, no. 6 (2018): 929–940, https://doi.org/10.1016/j.stem.2018.04.022.

[114] H. Wu and B. D. Humphreys, “Single Cell Sequencing and Kidney Organoids Generated From Pluripotent Stem Cells,” Clinical Journal of the American Society of Nephrology 15, no. 4 (2020): 550–556, https://doi.org/10.2215/cjn.07470619.

[115] T. Tran, N. O. Lindström, A. Ransick, et al., “In Vivo Developmental Trajectories of Human Podocyte Inform In Vitro Differentiation of Pluripotent Stem Cell-Derived Podocytes,” Developmental Cell 50, no. 1 (2019): 102–116, https://doi.org/10.1016/j.devcel.2019.06.001.

[116] N. O. Lindström, J. Guo, A. D. Kim, et al., “Conserved and Divergent Features of Mesenchymal Progenitor Cell Types Within the Cortical Nephrogenic Niche of the Human and Mouse Kidney,” American Society of Nephrology 29, no. 3 (2018): 806–824, https://doi.org/10.1681/asn.2017080890.

[117] H. Wu, F. Liu, Y. Shangguan, et al., “Integrating Spatial Transcriptomics With Single-Cell Transcriptomics Reveals a Spatiotemporal Gene Landscape of the Human Developing Kidney,” Cell & Bioscience 12, no. 1 (2022): 80, https://doi.org/10.1186/s13578-022-00801-x.

[118] G. Wang, B. Heijs, S. Kostidis, et al., “Spatial Dynamic Metabolomics Identifies Metabolic Cell Fate Trajectories in Human Kidney Differentiation,” Cell Stem Cell 29, no. 11 (2022): 1580–1593, https://doi.org/10.1016/j.stem.2022.10.008.

[119] M. Lassé, J. El Saghir, C. C. Berthier, et al., “An Integrated Organoid Omics Map Extends Modeling Potential of Kidney Disease,” Nature Communications 14, no. 1 (2023): 4903, https://doi.org/10.1038/s41467-023-39740-7.

[120] S. Jain and M. T. Eadon, “Spatial Transcriptomics in Health and Disease,” Nature Reviews. Nephrology 20, no. 10 (2024): 659–671, https://doi.org/10.1038/s41581-024-00841-1.

[121] S. Jiang, H. Yu, T. Zhao, et al., “A High-Definition Spatiotemporal Transcriptomic Atlas of Mammalian Kidney Development,” Innovation (Camb) 6, no. 4 (2025): 100767, https://doi.org/10.1016/j.xinn.2024.100767.

[122] L. J. Hale, S. E. Howden, B. Phipson, et al., “3D Organoid-Derived Human Glomeruli for Personalised Podocyte Disease Modelling and Drug Screening,” Nature Communications 9, no. 1 (2018): 5167, https://doi.org/10.1038/s41467-018-07594-z.

[123] M. Morais, P. Tian, C. Lawless, et al., “Kidney Organoids Recapitulate Human Basement Membrane Assembly in Health and Disease,” eLife 11 (2022): e73486, https://doi.org/10.7554/eLife.73486.

[124] Q. Wang, Y. Xiong, S. Zhang, et al., “The Dynamics of Metabolic Characterization in iPSC-Derived Kidney Organoid Differentiation via a Comparative Omics Approach,” Frontiers in Genetics 12 (2021): 632810, https://doi.org/10.3389/fgene.2021.632810.

[125] J. L. Davis, C. Kennedy, S. Clerkin, et al., “Single-Cell Multiomics Reveals the Complexity of TGFβ Signalling to Chromatin in iPSC-Derived Kidney Organoids,” Communications Biology 5, no. 1 (2022): 1301, https://doi.org/10.1038/s42003-022-04264-1.

[126] A. R. Ryan, A. R. England, C. P. Chaney, et al., “Vascular Deficiencies in Renal Organoids and Ex Vivo Kidney Organogenesis,” Developmental Biology 477 (2021): 98–116, https://doi.org/10.1016/j.ydbio.2021.04.009.

[127] D. A. D. Munro and J. A. Davies, “Vascularizing the Kidney in the Embryo and Organoid: Questioning Assumptions About Renal Vasculogenesis,” American Society of Nephrology 29, no. 6 (2018): 1593–1595, https://doi.org/10.1681/asn.2018020179.

[128] J. C. Maggiore, R. LeGraw, A. Przepiorski, et al., “A Genetically Inducible Endothelial Niche Enables Vascularization of Human Kidney Organoids With Multilineage Maturation and Emergence of Renin Expressing Cells,” Kidney International 106, no. 6 (2024): 1086–1100, https://doi.org/10.1016/j.kint.2024.05.026.

[129] C. W. van den Berg, S. J. Dumas, M. H. Little, and T. J. Rabelink, “Challenges in Maturation and Integration of Kidney Organoids for Stem Cell-Based Renal Replacement Therapy,” Kidney International 107, no. 2 (2025): 262–270, https://doi.org/10.1016/j.kint.2024.10.028.

[130] M. H. Little and S. B. Wilson, “Advances and Continuing Challenges in Differentiation of Stem Cells to Human Kidney Tissue,” Nature Reviews. Nephrology 22, no. 2 (2026): 122–136, https://doi.org/10.1038/s41581-025-01018-0.

[131] M. Shi, B. Crouse, N. Sundaram, et al., “Integrating Collecting Systems in Human Kidney Organoids Through Fusion of Distal Nephron to Ureteric Bud,” bioRxiv 32, no. 7 (2025), https://doi.org/10.1016/j.stem.2025.04.008.

[132] X. Lyu, J. Wang, and J. Su, “Intelligent Manufacturing for Osteoarthritis Organoids,” Cell Proliferation 58, no. 7 (2025): e70043, https://doi.org/10.1111/cpr.70043.

[133] B. DeMeo, C. Nesbitt, S. A. Miller, et al., “Active Learning Framework Leveraging Transcriptomics Identifies Modulators of Disease Phenotypes,” Science 224 (2025): 245–251, https://doi.org/10.1126/science.adi8577.

[134] R. Zhao, Q. Feng, Y. Xia, L. Liao, and S. Xie, “Iteration of Tumor Organoids in Drug Development: Simplification and Integration,” Pharmaceuticals 18, no. 10 (2025): 1540, https://doi.org/10.3390/ph18101540.

[135] L. Königer, C. Malkmus, D. Mahdy, et al., “ReBiA-Robotic Enabled Biological Automation: 3D Epithelial Tissue Production,” Advanced Science 11, no. 45 (2024): e2406608, https://doi.org/10.1002/advs.202406608.

Rights & permissions

2026 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.